Dr. Brian Patrick Quaranta, MD

Dr. Quaranta practices at Sovah Health - Danville in Danville, Virginia, part of Lifepoint Health.

Dr. Quaranta's NPI, 1083600357, was assigned on September 22, 2005. Dr. Quaranta graduated from Rutgers New Jersey Medical School in 1998. Dr. Quaranta's North Carolina license number on file is 2002200774.

Dr. Quaranta's primary practice is Sovah Health - Danville, at 142 South Main Street, Danville, VA 24541 in Danville City. The practice phone is (434) 799-2100.

Dr. Quaranta's primary practice is Sovah Health - Danville in Danville, Virginia, part of Lifepoint Health. Dr. Quaranta is also affiliated with Sentara Halifax Regional Hospital. The medical group on file is Sovah Physician Practices. Dmand AI also links Dr. Quaranta to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Quaranta practices, 2 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Quaranta's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Quaranta is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Quaranta's licenses on file in 2 states: North Carolina and Virginia.

Dmand AI lists bladder cancer radiation, bone cancer radiation, breast cancer radiation, cancer radiation-upper GI, colorectal cancer radiation, head & neck cancer radiation, lung cancer radiation and prostate cancer radiation among the conditions Dr. Quaranta treats.

CMS data shows 1,525 Medicare services from Dr. Quaranta across 13 procedure codes in 2024, for 162 Medicare patients. Medicare paid $91,837 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 162 Medicare patients who saw Dr. Quaranta in 2024. The largest group is 75 to 84, with 71 patients. 75% of them have cancer, and 75% have high blood pressure. 7% are also on Medicaid. Their average risk score is 1.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Quaranta's median patient age at 70, with 42% women.

In 2024, Dr. Quaranta wrote 272 Medicare Part D claims for 96 patients. 94% of them were for generic drugs. CMS names the drug for 177 of them, across 4 drugs with 11 or more claims each, at $2,651 in total drug cost. In 2023, CMS named 97 claims across 1 drug.

Dr. Quaranta accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 8 papers to Dr. Quaranta, published from 2010 to 2021. 2021 was the busiest year, with 2. Dr. Quaranta's most frequent co-authors are Michael R. Haake, MD, Bridget Fey Koontz, MD and Joanne Kurtzberg, MD.

CMS Open Payments shows 54 general payments to Dr. Quaranta from 23 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $112.

Dmand AI lists 1 award for Dr. Quaranta, most recently CMS Stage 1 EHR in 2014.

Dr. Quaranta graduated from Rutgers New Jersey Medical School in 1998.

Dr. Quaranta is in network with 17 carriers, including Blue Cross Blue Shield of Michigan, United Healthcare and Blue Cross and Blue Shield of North Carolina. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.